Statistics
Publications
2
Citations
95
H-Index
2
Active since
2022
Affiliations
Jiexiao Li is an author at Huazhong University of Science and Technology specializing in cancer immunotherapy, programmed death-ligand 1 inhibitors, and tumor immunology.
Publications per year
2022–2025
2
2
TSH-TSHR axis promotes tumor immune evasion
Zhenghao Wu, Zihan Xi, Yunxiao Xiao et al. · Journal for ImmunoTherapy of Cancer · 2022 · 57 citations · Full text
Medicine, Immunology, Oncology +17
1–2 of 2